Volume 2, Issue 3, September 2020, Pages 125 - 128
B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia
Authors
Meghali Goswami1, 2, 
, Katherine E. Lindblad1, , Rahul Ramraj1, Pradeep K. Dagur3, Julie Thompson1, J. Philip McCoy3, Christopher S. Hourigan1, *,
, Katherine E. Lindblad1, , Rahul Ramraj1, Pradeep K. Dagur3, Julie Thompson1, J. Philip McCoy3, Christopher S. Hourigan1, *, 1Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
2Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA
3Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
*Corresponding author. Email: hourigan@nih.gov
Corresponding Author
Christopher S. Hourigan
Received 23 April 2020, Accepted 17 June 2020, Available Online 29 July 2020.
- DOI
- 10.2991/chi.k.200712.001How to use a DOI?
- Keywords
- AML; adaptive immunity; B lymphocyte; Tregs; PD-1; immunotherapy
- Copyright
- © 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Download article (PDF)
View full text (HTML)
Cite this article
TY - JOUR AU - Meghali Goswami AU - Katherine E. Lindblad AU - Rahul Ramraj AU - Pradeep K. Dagur AU - Julie Thompson AU - J. Philip McCoy AU - Christopher S. Hourigan PY - 2020 DA - 2020/07/29 TI - B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia JO - Clinical Hematology International SP - 125 EP - 128 VL - 2 IS - 3 SN - 2590-0048 UR - https://doi.org/10.2991/chi.k.200712.001 DO - 10.2991/chi.k.200712.001 ID - Goswami2020 ER -